Description
A major phase 2 metabolite of pitavastatin; formed when pitavastatin undergoes glucuronidation by UGT1A1, UGT1A3, or UGT2B7 to form pitavastatin glucuronide which then undergoes non-enzymatic conversion to the lactone form, can be converted back to pitavastatin via hydrolysis
Formal name: 6S-[(1E)-2-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]ethenyl]tetrahydro-4R-hydroxy-2H-pyran-2-one
Synonyms:
Molecular weight: 403.5
CAS: 141750-63-2
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Xenobiotic Metabolites||Research Area|Toxicology|Drug Metabolism|Drug Metabolites